BORAY
Bora Pharmaceuticals Co., Ltd.
Price Chart
Latest Quote
$2.45
+0.00 (+0.00%)
Current Price
| Previous Close | $2.45 |
| Open | $4.05 |
| Day High | $4.55 |
| Day Low | $4.05 |
| Volume | 200 |
Stock Information
Note: Financial values converted from TWD to USD
| Quarterly Dividend / Yield | $0.06 / 2.57% |
| Shares Outstanding | 127.57M |
| Quarterly Dividend Yield | 2.57% |
| Quarterly Dividend | $0.06 |
| Total Debt | $670.96M |
| Cash Equivalents | $261.05M |
| Revenue | $601.51M |
| Net Income | $55.95M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $312.53M |
| P/E Ratio | 5.33 |
| EPS (TTM) | $0.46 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $17.33B |
| Sales | $601.51M |
| Income | $55.95M |
| Book/sh | $0.73 |
| Cash/sh | $66.54 |
Financial Ratios
| Quick Ratio | 1.01 |
| Current Ratio | 1.30 |
| Debt/Eq | 124.41 |
| EPS Growth TTM | -9.90% |
Returns & Margins
| ROA | 4.01% |
| ROE | 12.05% |
| Gross Margin | 39.97% |
| Operating Margin | 16.75% |
| Profit Margin | 7.91% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/S | 0.02 |
| P/B | 3.34 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.45 |
| SMA50 | $3.20 |
| RSI | nan |
| Shares Float | 371.47M |
| Volatility | 0.44 |
Performance History
| Week | +0.00% |
| Month | -65.00% |
| Quarter | -3.05% |
| YTD | -3.05% |
| 10 Years | -3.05% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-28 | $2.45 | 0 |
| 2026-10-27 | $2.45 | 0 |
| 2026-10-26 | $2.45 | 0 |
| 2026-10-23 | $2.45 | 0 |
| 2026-10-22 | $2.45 | 0 |
| 2026-10-21 | $2.45 | 0 |
| 2026-10-20 | $2.45 | 0 |
| 2026-10-19 | $2.45 | 0 |
| 2026-10-16 | $2.45 | 0 |
| 2026-10-15 | $2.45 | 0 |
| 2026-10-14 | $2.45 | 0 |
| 2026-10-13 | $2.45 | 0 |
| 2026-10-12 | $2.45 | 0 |
| 2026-10-09 | $2.45 | 0 |
| 2026-10-08 | $2.45 | 0 |
| 2026-10-07 | $2.45 | 0 |
| 2026-10-06 | $2.45 | 0 |
| 2026-10-05 | $2.45 | 0 |
| 2026-10-02 | $2.45 | 0 |
| 2026-10-01 | $2.45 | 514 |
| 2026-09-30 | $7.00 | 0 |
About Bora Pharmaceuticals Co., Ltd.
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.
đ° Latest News
No news articles available at the moment. Check back later for updates on BORAY.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $347,656,217 | $300,152,260 | $224,546,166 | $236,160,451 |
| Cost Of Revenue | $347,656,217 | $300,152,260 | $224,546,166 | $236,160,451 |
| Total Revenue | $592,267,920 | $542,817,851 | $442,314,610 | $326,889,801 |
| Operating Revenue | $592,267,920 | $542,817,851 | $442,314,610 | $326,889,801 |
| Expenses | ||||
| Interest Expense | $15,095,378 | $14,942,749 | $5,333,884 | $3,386,712 |
| Total Expenses | $489,623,731 | $427,318,223 | $278,810,402 | $267,016,388 |
| Other Non Operating Income Expenses | $90,948,419 | $10,352,012 | $-31,577,187 | $827,062 |
| Net Non Operating Interest Income Expense | $-15,095,378 | $-14,942,749 | $-5,333,884 | $-3,386,712 |
| Interest Expense Non Operating | $15,095,378 | $14,942,749 | $5,333,884 | $3,386,712 |
| Operating Expense | $141,967,514 | $127,165,963 | $54,264,236 | $30,855,937 |
| Selling And Marketing Expense | $45,642,537 | $35,827,499 | $13,926,396 | $8,102,262 |
| General And Administrative Expense | $75,386,557 | $71,438,295 | $31,050,524 | $18,733,055 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $136,534,733 | $128,213,371 | $94,385,187 | $43,356,467 |
| Net Interest Income | $-15,095,378 | $-14,942,749 | $-5,333,884 | $-3,386,712 |
| Normalized Income | $136,525,046 | $86,396,427 | $94,385,187 | $43,356,467 |
| Net Income From Continuing And Discontinued Operation | $92,864,162 | $120,001,092 | $94,385,187 | $43,356,467 |
| Net Income Common Stockholders | $92,864,162 | $120,001,092 | $94,385,187 | $43,356,467 |
| Net Income | $92,864,162 | $120,001,092 | $94,385,187 | $43,356,467 |
| Net Income Including Noncontrolling Interests | $94,880,390 | $123,159,390 | $95,686,551 | $43,655,776 |
| Net Income Discontinuous Operations | $-43,670,571 | $-8,212,279 | - | - |
| Net Income Continuous Operations | $138,550,962 | $131,371,669 | $95,686,551 | $43,655,776 |
| Pretax Income | $164,399,704 | $162,695,368 | $126,593,137 | $57,313,762 |
| Special Income Charges | $11,494 | $51,787,597 | $0 | - |
| Operating Income | $102,644,189 | $115,499,628 | $163,504,208 | $59,873,412 |
| Gross Profit | $244,611,703 | $242,665,591 | $217,768,444 | $90,729,350 |
| Per Share | ||||
| Diluted EPS | - | $0.91 | $0.76 | $0.37 |
| Basic EPS | - | $0.98 | $0.78 | $0.37 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,807 | $9,970,653 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $213,328,498 | $157,819,402 | $150,812,082 | $70,829,617 |
| Total Unusual Items | $11,494 | $51,787,597 | $0 | - |
| Total Unusual Items Excluding Goodwill | $11,494 | $51,787,597 | $0 | - |
| Reconciled Depreciation | $33,844,911 | $31,968,883 | $18,885,061 | $10,129,143 |
| EBITDA (Bullshit earnings) | $213,339,992 | $209,606,999 | $150,812,082 | $70,829,617 |
| EBIT | $179,495,081 | $177,638,116 | $131,927,021 | $60,700,474 |
| Diluted NI Availto Com Stockholders | $92,864,162 | $120,001,092 | $94,385,187 | $43,356,467 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $-2,016,229 | $-3,158,298 | $-1,301,364 | $-299,309 |
| Tax Provision | $25,848,742 | $31,323,698 | $30,906,585 | $13,657,987 |
| Other Special Charges | $-11,494 | - | - | - |
| Restructuring And Mergern Acquisition | $0 | $-51,787,597 | $0 | - |
| Research And Development | $20,938,419 | $19,900,169 | $9,287,316 | $4,020,621 |
| Selling General And Administration | $121,029,095 | $107,265,794 | $44,976,919 | $26,835,317 |
| Diluted Average Shares | - | $4,193,839 | $3,870,247 | $3,688,544 |
| Basic Average Shares | - | $3,804,946 | $3,749,946 | $3,647,510 |
Fetched: 2026-07-10
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $284,604,197 | $163,239,942 | $106,210,225 | $74,161,819 |
| Total Assets | $1,392,791,792 | $1,417,569,328 | $782,898,499 | $708,983,783 |
| Total Non Current Assets | $790,449,240 | $689,398,590 | $452,586,165 | $327,697,769 |
| Other Non Current Assets | $22,751,527 | $16,883,909 | $8,654,249 | $2,645,901 |
| Non Current Deferred Taxes Assets | $36,459,071 | $37,074,695 | $32,543,173 | $25,842,138 |
| Investmentin Financial Assets | $10,618,770 | $10,407,457 | $662,160 | $2,004,828 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $3,353,321 | $3,088,867 | $0 | $72,764 |
| Goodwill And Other Intangible Assets | $194,507,416 | $234,815,323 | $176,769,689 | $66,889,828 |
| Current Assets | $602,342,552 | $728,170,738 | $330,312,334 | $381,286,014 |
| Other Current Assets | $6,937,609 | $3,564,260 | $4,318,029 | $2,089,958 |
| Assets Held For Sale Current | $8,960,940 | $0 | - | - |
| Prepaid Assets | $21,039,715 | $18,409,046 | $24,963,401 | $9,077,343 |
| Inventory | $106,231,188 | $171,391,169 | $67,202,001 | $60,640,980 |
| Other Receivables | $25,383,566 | $31,957,109 | $4,736,108 | $11,165,992 |
| Accounts Receivable | $273,784,237 | $318,400,609 | $123,314,044 | $188,389,300 |
| Gross Accounts Receivable | $273,784,237 | $318,400,609 | $123,314,044 | $188,389,300 |
| Cash Cash Equivalents And Short Term Investments | $160,005,298 | $184,448,545 | $105,778,752 | $109,922,441 |
| Cash And Cash Equivalents | $158,138,833 | $181,572,299 | $95,106,343 | $102,209,041 |
| Non Current Prepaid Assets | - | - | $1,374,003 | $1,192,935 |
| Debt | ||||
| Net Debt | $385,060,497 | $382,738,263 | $33,864,379 | $113,539,312 |
| Total Debt | $567,791,748 | $591,178,305 | $156,050,588 | $236,686,118 |
| Long Term Debt And Capital Lease Obligation | $389,520,969 | $469,407,371 | $108,614,318 | $144,334,540 |
| Long Term Debt | $367,439,671 | $446,171,574 | $84,837,436 | $125,742,495 |
| Current Debt And Capital Lease Obligation | $178,270,779 | $121,770,934 | $47,436,270 | $92,351,578 |
| Current Debt | $175,759,659 | $118,138,988 | $44,133,286 | $90,005,857 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $848,554,648 | $952,726,030 | $416,407,993 | $548,864,916 |
| Total Non Current Liabilities Net Minority Interest | $433,624,228 | $522,624,479 | $160,082,889 | $221,942,316 |
| Other Non Current Liabilities | $2,391,197 | $2,065,849 | $9,096,499 | $14,782,146 |
| Non Current Deferred Taxes Liabilities | $30,792,082 | $39,118,522 | $24,417,643 | $23,138,799 |
| Current Liabilities | $414,930,420 | $430,101,552 | $256,325,104 | $326,922,600 |
| Other Current Liabilities | $105,461,564 | $126,196,644 | $58,448,138 | $63,278,159 |
| Payables | $117,257,104 | $141,648,333 | $89,577,219 | $142,774,641 |
| Other Payable | $78,494,550 | $102,064,106 | $47,556,442 | $121,265,389 |
| Total Tax Payable | $10,000,405 | $15,086,345 | $30,757,227 | $7,433,684 |
| Accounts Payable | $28,762,148 | $24,497,882 | $11,263,550 | $14,075,567 |
| Dividends Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $479,111,614 | $398,055,264 | $282,979,914 | $141,051,647 |
| Total Equity Gross Minority Interest | $544,237,144 | $464,843,298 | $366,490,505 | $160,118,866 |
| Stockholders Equity | $479,111,614 | $398,055,264 | $282,979,914 | $141,051,647 |
| Other Equity Interest | $-5,044,418 | $11,231,186 | $2,298,997 | $1,217,699 |
| Retained Earnings | $228,207,112 | $198,165,683 | $136,217,171 | $71,912,037 |
| Long Term Equity Investment | $177,405,653 | $42,674 | $0 | - |
| Other | ||||
| Treasury Shares Number | $11,724 | $9,866 | $10,763 | $14,563 |
| Ordinary Shares Number | $3,955,496 | $3,842,636 | $3,779,246 | $3,644,680 |
| Share Issued | $3,967,220 | $3,852,502 | $3,790,009 | $3,659,242 |
| Tangible Book Value | $284,604,197 | $163,239,942 | $106,210,225 | $74,161,819 |
| Invested Capital | $1,022,310,943 | $962,365,826 | $411,950,636 | $356,799,999 |
| Working Capital | $187,412,132 | $298,069,186 | $73,987,230 | $54,363,414 |
| Capital Lease Obligations | $24,592,419 | $26,867,743 | $27,079,866 | $20,937,765 |
| Total Capitalization | $846,551,284 | $844,226,839 | $367,817,349 | $266,794,142 |
| Minority Interest | $65,125,531 | $66,788,034 | $83,510,592 | $19,067,219 |
| Treasury Stock | $4,182,874 | $1,345,035 | $1,587,590 | $1,653,750 |
| Additional Paid In Capital | $188,631,170 | $137,311,116 | $103,362,511 | $38,511,713 |
| Capital Stock | $39,740,531 | $32,180,383 | $31,615,407 | $23,577,187 |
| Common Stock | $39,740,531 | $32,180,383 | $31,615,407 | $23,577,187 |
| Non Current Deferred Revenue | $2,768,284 | $0 | $0 | $130,326 |
| Long Term Capital Lease Obligation | $22,081,299 | $23,235,797 | $23,776,882 | $18,592,045 |
| Long Term Provisions | $3,095,938 | $4,019,312 | $6,753,208 | $10,644,032 |
| Current Capital Lease Obligation | $2,511,120 | $3,631,946 | $3,302,984 | $2,345,720 |
| Current Provisions | $3,471,810 | $7,728,632 | $4,501,713 | $4,185,802 |
| Available For Sale Securities | $7,265,450 | $7,318,590 | $662,160 | $1,932,065 |
| Investment Properties | $365,655 | $511,151 | $530,090 | $549,028 |
| Net PPE | $348,341,147 | $389,663,381 | $233,426,804 | $228,573,110 |
| Gross PPE | $348,341,147 | $389,663,381 | $233,426,804 | $228,573,110 |
| Other Properties | $348,341,147 | $389,663,381 | $233,426,804 | $227,395,593 |
| Other Short Term Investments | $1,866,465 | $2,876,246 | $10,672,409 | $7,713,400 |
| Construction In Progress | - | - | $4,672,035 | $1,177,517 |
Fetched: 2026-07-10
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $108,916,118 | $9,125,779 | $99,161,196 | $56,374,876 |
| Operating Activities | ||||
| Operating Cash Flow | $140,281,244 | $30,526,539 | $143,709,727 | $62,611,327 |
| Investing Activities | ||||
| Capital Expenditure | $-31,365,126 | $-21,400,760 | $-44,548,530 | $-6,236,450 |
| Investing Cash Flow | $-105,271,899 | $-332,656,434 | $-76,550,743 | $-133,353,821 |
| Net Other Investing Changes | $-21,858,491 | $-5,084,289 | $340,207 | $1,479,193 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-3,111,263 | $-12,120,826 | $0 | $-1,653,750 |
| Issuance Of Capital Stock | $3,973,150 | $2,955,738 | $1,057,065 | $121,356 |
| Financing Cash Flow | $-42,889,049 | $375,984,868 | $-76,009,938 | $143,122,355 |
| Net Other Financing Charges | $-3,372,913 | $1,434,463 | $2,189,322 | $17,970,907 |
| Cash Dividends Paid | $-45,132,134 | $-38,400,325 | $-19,285,261 | $-7,438,388 |
| Net Common Stock Issuance | $861,886 | $-9,165,089 | $1,057,065 | $-1,532,395 |
| Common Stock Issuance | $3,973,150 | $2,955,738 | $1,057,065 | $121,356 |
| Dividends Received Cfi | $29,809 | $24,421 | - | - |
| Other | ||||
| Repayment Of Debt | $-40,871,699 | $-87,380,546 | $-202,433,283 | $-58,512,087 |
| Issuance Of Debt | $56,996,575 | $524,674,192 | $149,649,890 | $197,065,758 |
| End Cash Position | $158,138,833 | $181,572,299 | $95,106,343 | $102,209,041 |
| Beginning Cash Position | $181,572,299 | $95,106,343 | $102,209,041 | $28,368,708 |
| Effect Of Exchange Rate Changes | $-15,553,763 | $12,610,983 | $1,748,256 | $1,460,472 |
| Changes In Cash | $-7,879,704 | $73,854,973 | $-8,850,953 | $72,379,860 |
| Interest Paid Cff | $-8,308,591 | $-11,920,197 | $-4,859,395 | $-3,271,866 |
| Common Stock Payments | $-3,111,263 | $-12,120,826 | $0 | $-1,653,750 |
| Net Issuance Payments Of Debt | $16,124,876 | $437,293,646 | $-52,783,392 | $138,553,672 |
| Net Short Term Debt Issuance | $42,668,142 | $56,803,296 | $-43,539,186 | $24,057,065 |
| Short Term Debt Issuance | $42,668,142 | $56,803,296 | $0 | $24,057,065 |
| Net Long Term Debt Issuance | $-26,543,266 | $380,490,350 | $-9,244,206 | $114,496,607 |
| Long Term Debt Payments | $-40,871,699 | $-87,380,546 | $-158,894,097 | $-58,512,087 |
| Long Term Debt Issuance | $14,328,433 | $467,870,896 | $149,649,890 | $173,008,693 |
| Net Investment Purchase And Sale | $757,850 | $13,194,742 | $-1,298,997 | $10,091,609 |
| Sale Of Investment | $778,719 | $79,049,652 | $1,671,069 | $0 |
| Purchase Of Investment | $-20,870 | $-65,854,910 | $-2,970,066 | $10,091,609 |
| Net Business Purchase And Sale | $-54,094,537 | $-319,782,587 | $-31,148,456 | $-139,870,361 |
| Purchase Of Business | $-54,094,537 | $-319,782,587 | $-40,132,476 | $-140,617,931 |
| Net Intangibles Purchase And Sale | $-1,369,798 | $-4,951,097 | $-35,275,387 | $-168,515 |
| Sale Of Intangibles | $1,068,340 | $0 | - | - |
| Purchase Of Intangibles | $-2,438,139 | $-4,951,097 | $-35,275,387 | $-168,515 |
| Net PPE Purchase And Sale | $-28,736,731 | $-16,057,625 | $-9,168,110 | $-4,885,746 |
| Sale Of PPE | $190,257 | $392,038 | $105,034 | $1,182,189 |
| Purchase Of PPE | $-28,926,988 | $-16,449,664 | $-9,273,144 | $-6,067,936 |
| Taxes Refund Paid | $-14,791,989 | $-32,909,576 | $-27,923,935 | $-11,454,897 |
| Interest Received Cfo | $914,216 | $2,847,714 | $1,960,939 | $353,975 |
| Change In Working Capital | $68,139,111 | $-89,183,592 | $-15,323,169 | $134,189 |
| Change In Other Current Liabilities | $-21,170,664 | $-4,674,994 | $-4,793,453 | $5,103,507 |
| Change In Other Current Assets | $640,948 | $1,355,189 | $1,978,507 | $-1,466,359 |
| Change In Payable | $-2,148,330 | $-30,228,508 | $-70,911,912 | $48,425,929 |
| Change In Prepaid Assets | $-706,797 | $2,434,837 | $-286,880 | $-3,306,940 |
| Change In Inventory | $63,885,374 | $-10,647,147 | $-3,877,990 | $3,095,845 |
| Change In Receivables | $32,499,346 | $-42,673,499 | $66,904,374 | $-48,492,899 |
| Other Non Cash Items | $14,557,843 | $-38,568,497 | $3,634,532 | $3,550,025 |
| Stock Based Compensation | $2,449,010 | $4,235,640 | $3,202,498 | $991,341 |
| Depreciation And Amortization | $33,844,911 | $31,968,883 | $18,885,061 | $10,129,143 |
| Amortization Cash Flow | $11,908,828 | $10,104,878 | $5,799,838 | $2,068,652 |
| Depreciation | $21,936,083 | $21,864,005 | $13,085,223 | $8,060,491 |
| Gain Loss On Investment Securities | $-11,849,271 | $-384,438 | $32,525,013 | $1,520,371 |
| Gain Loss On Sale Of PPE | $-1,169,885 | $871,916 | $155,650 | $73,418 |
| Gain Loss On Sale Of Business | $-80,722,964 | $0 | - | - |
| Net Income From Continuing Operations | $110,084,664 | $151,647,367 | $126,593,137 | $57,313,762 |
| Short Term Debt Payments | - | $0 | $-43,539,186 | $0 |
| Sale Of Business | - | $0 | $8,984,021 | $747,570 |
Fetched: 2026-07-10